What top creators are saying about Janux Therapeutics, Inc.(JANX)
A biopharmaceutical company developing T cell engager immunotherapies.
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Not enough scored insights about Janux Therapeutics, Inc. in the last 30 days yet.
Top creators covering Janux Therapeutics, Inc. (JANX)
The 1 sources with the most insights about Janux Therapeutics, Inc. on Kazuha.
Latest insights about Janux Therapeutics, Inc. (JANX)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Tuesday, December 2, 2025
Mentioned as being 'down 50%' due to 'real bad data,' serving as a clear warning of significant negative developments.
Tuesday, December 2, 2025
Mentioned as being 'down 50%' due to 'real bad data,' serving as a clear warning of significant negative developments.
Discussed alongside Janux Therapeutics, Inc. (JANX)
Other assets that creators frequently mention in the same content as Janux Therapeutics, Inc..
Frequently asked
Which podcasters and creators cover Janux Therapeutics, Inc. (JANX) the most?
The most active sources covering Janux Therapeutics, Inc. (JANX) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about Janux Therapeutics, Inc. (JANX) are on Kazuha?
Kazuha has indexed 1 AI-extracted insight about Janux Therapeutics, Inc. (JANX) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside Janux Therapeutics, Inc. (JANX)?
Creators covering Janux Therapeutics, Inc. (JANX) most frequently also discuss AZN, IONQ, NVDA, CAPR, REPL. See the "Discussed alongside" section above for full asset pages.